Richard Pzena
Pzena Investment Management
Richard Pzena Alexion Pharmaceuticals Inc stake
total: 584
Pzena Investment Management ALXN trades
- Total transactions:
- 7
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 4
- Held since:
- 2020 Q1
- Held for:
- 6 quarters
- Latest activity:
- 2021 Q3
According to 2026 Q2 report, Richard Pzena doesn't hold any Alexion Pharmaceuticals Inc (ALXN) shares. To date, the estimated cost basis is nearly $91.22 for "buy" trades and estimated average "sell" price is $156.21. Pzena Investment Management first purchased ALXN in 2020 Q1, initially acquiring 7,617 shares. Since the initial investment in Alexion Pharmaceuticals Inc (ALXN), Pzena Investment Management has made 6 more transactions.
When did Richard Pzena sell Alexion Pharmaceuticals Inc (ALXN)?
Richard Pzena sold off the entire Alexion Pharmaceuticals Inc (ALXN) position in 2021 Q3.
When did Richard Pzena buy Alexion Pharmaceuticals Inc (ALXN)?
Richard Pzena first invested in Alexion Pharmaceuticals Inc (ALXN) in 2020 Q1 at the reported quarter-end price of $89.80 per share.
What's the cost basis of Pzena Investment Management's ALXN stake?
The estimated cost basis for Alexion Pharmaceuticals Inc (ALXN) stake is around $91.22 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $91.22
- Weighted AVG sell price:
- $156.21
Richard Pzena's historical trades in Alexion Pharmaceuticals Inc
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q3
|
0.00%
|
0
|
$183.67
|
|
-100% (-3,430)
|
-0%
|
|
2021 Q2
|
0.00%
|
3,430
|
$183.67
|
$630,000
|
-18.82% (-795)
|
-0%
|
|
2021 Q1
|
0.00%
|
4,225
|
$152.90
|
$646,000
|
+4.35% (+176)
|
+0%
|
|
2020 Q4
|
0.00%
|
$156.33
|
-17.75% (-874)
|
|||
|
2020 Q3
|
0.00%
|
$114.36
|
-17.74% (-1,062)
|
|||
|
2020 Q2
|
0.00%
|
$112.28
|
-21.43% (-1,632)
|
|||
|
2020 Q1
|
0.01%
|
$89.80
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.